Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q73816365)
Watch
English
Ribonucleotide reductase: an old target with new potential
scientific article published on 01 December 2003
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12921942
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12921942%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
title
Ribonucleotide reductase: an old target with new potential
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12921942
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12921942%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
author name string
B Douglas Smith
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12921942
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12921942%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
Judith E Karp
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12921942
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12921942%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
publication date
1 December 2003
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12921942
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12921942%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
published in
Leukemia Research
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12921942
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12921942%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
volume
27
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12921942
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12921942%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
issue
12
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12921942
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12921942%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
page(s)
1075-1076
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12921942
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12921942%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
cites work
Ribonucleotide Reductase—a Radical Enzyme
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900248-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900248-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900248-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900248-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900248-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900248-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0145-2126(03)00248-0
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12921942
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12921942%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
PubMed publication ID
12921942
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12921942
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12921942%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit